Group items tagged

"Given the startling statistics of the opioid epidemic, it's no surprise that many are searching for safer ways to manage their pain. Whether they want to avoid the risks associated with conventional medications or feel they've exhausted other options, more and more people are turning to cannabidiol (CBD) for pain. So, what exactly is CBD? Does it really relieve pain? What does science say? Let's look at some CBD facts and examine the evidence around using CBD for pain."

CBD FOR profit arm of wholistic research

new project apollo patient. Co-Founder & President Company NameWholistic Research and Education Foundation Dates EmployedMay 2017 - Present Employment Duration1 yr 2 mos LocationGreater San Diego Area Wholistic Research and Education Foundation is a California-based nonprofit dedicated to exploring the health benefits of CBD-rich therapeutics. Our mission is to fund clinical and scientific research to better understand the "if, how and why" behind the potential healing power of hemp and cannabis across a multitude of ailments, as well as work to increase safe and legal access to those in need via advocacy and education. Co-Founder Company NameMana Artisan Botanics Dates EmployedMay 2017 - Present Employment Duration1 yr 2 mos LocationKona, Hawaii Mana Artisan Botanics is a purpose-driven hemp company based on the Big Island of Hawaii. We offer pure hemp extracts infused with sustainably grown Hawaiian herbs and spices - nature's mana. Each product is hand crafted artisan style, in small batches. We take great care to source our ingredients from conscientious farmers, supporting local and organic whenever available. All of our products are simple, pure and good for body and soil.

UCSD received a 5 million dollar grant from the NOORDA foundation. The research product will be slow in coming. NOORDA wants to work with N=1 patients

Abstract: INTRODUCTION: Spasticity in chronic spinal cord injury is a condition that can have negative repercussions on the patient's quality of life. Its treatment is complex and sometimes the outcome is insufficient. Cannabinoids have recently been used in multiple sclerosis to successfully treat spasticity that is refractory to other therapies. AIM: To quantify the clinical response of a group of patients with spastic chronic spinal cord injury to the orally administered drug delta-9-tetrahydrocannabinol-cannabidiol (Sativex®) as medication for use in special situations. PATIENTS AND METHODS: The research consists of a six-month observational study in patients with chronic spinal cord injuries with refractory spasticity. The variables collected were: modified Ashworth scale, Penn spasm frequency scale, Numeric Rating Scale, and Visual Analogue Scale for pain. Additionally, clinical variables and side effects of the treatment were also collected. RESULTS: Fifteen patients took part in this study. A significant improvement was observed on three of the scales recorded: modified Ashworth scale (z = -2.97; p = 0.003), Penn spasm frequency scale (z = -2.76; p = 0.006) and Numeric Rating Scale (z = -3.21; p = 0.001). The use of the drug was withdrawn in two patients due to side effects. CONCLUSIONS: Sativex can be considered an alternative in patients with spasticity associated with chronic spinal cord injury for whom other therapeutic measures have been insufficient. Further studies need to be conducted before the use of this drug can be recommended and so as to define a complete profile of its long-term side effects.

"Blake is a program officer for the James Walton Fund of the Individually Directed Program. Prior to joining the foundation, Blake was a social studies teacher, social- emotional development coordinator, coach and charter school consultant in the Chicago Public Schools. His work continues to focus on improving the educational experience and outcomes for those people and groups, who are traditionally underserved by schooling."

"The Walton Family Foundation is, at its core, a family-led foundation. The children and grandchildren of our founders, Sam and Helen Walton, lead the foundation and create access to opportunity for people and communities. We believe the best ideas can come from anywhere, so we stay open to new thinking from all over. And we partner with those who are closest to the problem because they're usually closest to the solution. "

Recommended by Sharon Wampler Randy's Remedy products are powered by Cannaka, a botanically complete blend of natural cannabinoids and terpenes derived from hemp. Natural cannabinoids are active non-dietary ingredients that target the endocannabinoid system which is responsible for modulating homeostasis in the body. These active ingredients, combined with essential terpenes support the endocannabinoid system and promote a healthy inflammatory response. Developed by the Strause Group; Linda, Tyler, and Brendon Strause, Randy's Remedy are the products they wished they had when their husband and father, Randy, was diagnosed with glioblastoma multiforme, an incurable brain cancer. Together they helped develop Cannaka and Randy's Remedy products delivering all the healthful benefits of natural cannabinoids and terpenes from hemp.